Literature DB >> 27557832

Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis.

Albert J Farias1,2, India J Ornelas3, Sarah D Hohl4, Steven B Zeliadt3,5, Ryan N Hansen6, Christopher I Li4,7, Beti Thompson3,4.   

Abstract

PURPOSE: To better understand how physicians communicate with breast cancer patients about adjuvant endocrine therapy (AET), we explored, from the breast cancer patient's perspective, dimensions of the patient-provider communication among women who were on active AET treatment.
METHODS: Qualitative methods using semi-structured in-depth interviews were conducted with breast cancer patients (n = 22) who filled a prescription for AET in the previous 12 months. Interview questions aimed to elicit experiences with AET. We reviewed and coded interview transcripts using qualitative principles of inductive reasoning to identify concepts and themes from interview data.
RESULTS: We grouped emergent themes into four major functions of physician-patient communication: (1) information exchange, (2) decision-making to take and continue AET, (3) enabling patient self-management and monitoring potential side effects, and (4) emotional support. Physicians exchanged information with patients in a way that they understood and enhanced patient's health literacy regarding the benefits and knowledge of AET. Physicians empowered patients to make decisions about their care. Patients expressed trust and confidence in their physician which helped them seek care when needed. Patients reported a high degree of self-efficacy to self-manage AET and were continuing treatment despite potential side effects.
CONCLUSIONS: The results from our study suggest that women's interactions and communication with their physician may be an important factor that contributes to the continued use of AET. Physicians who can communicate information about AET treatment benefits, purpose, and expectations in a way that patients can understand is a critical aspect of care that needs to be further studied.

Entities:  

Keywords:  Adjuvant endocrine therapy; Breast cancer; Physician-patient communication; Qualitative study; Survivors

Mesh:

Year:  2016        PMID: 27557832      PMCID: PMC5130881          DOI: 10.1007/s00520-016-3389-6

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  31 in total

1.  Endocrine therapy for breast cancer: assessing an array of women's treatment experiences and perceptions, their perceived self-efficacy and nonadherence.

Authors:  Hans Wouters; Anne M Stiggelbout; Marcel L Bouvy; Gemma A Maatman; Erica C G Van Geffen; Robbert Vree; Johan W Nortier; Liset Van Dijk
Journal:  Clin Breast Cancer       Date:  2014-06-02       Impact factor: 3.225

Review 2.  Adherence to endocrine therapy in breast cancer adjuvant and prevention settings.

Authors:  Rowan T Chlebowski; Jisang Kim; Reina Haque
Journal:  Cancer Prev Res (Phila)       Date:  2014-01-17

Review 3.  The qualitative research interview.

Authors:  Barbara Dicicco-Bloom; Benjamin F Crabtree
Journal:  Med Educ       Date:  2006-04       Impact factor: 6.251

Review 4.  Knowledge, attitudes and beliefs of patients and carers regarding medication adherence: a review of qualitative literature.

Authors:  Maria Kelly; Suzanne McCarthy; Laura Jane Sahm
Journal:  Eur J Clin Pharmacol       Date:  2014-10-04       Impact factor: 2.953

5.  Patient and physician beliefs about control over health: association of symmetrical beliefs with medication regimen adherence.

Authors:  Alan J Christensen; M Bryant Howren; Stephen L Hillis; Peter Kaboli; Barry L Carter; Jamie A Cvengros; Kenneth A Wallston; Gary E Rosenthal
Journal:  J Gen Intern Med       Date:  2010-02-20       Impact factor: 5.128

6.  Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness.

Authors:  R Horne; J Weinman
Journal:  J Psychosom Res       Date:  1999-12       Impact factor: 3.006

7.  Cancer survivorship and agency model: implications for patient choice, decision making, and influence.

Authors:  Dan O'Hair; Melinda M Villagran; Elaine Wittenberg; Kenneth Brown; Monica Ferguson; Harry T Hall; Timothy Doty
Journal:  Health Commun       Date:  2003

8.  Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer.

Authors:  Lee S Schwartzberg; Patrick Cobb; Frank Senecal; David Henry; Kimary Kulig; Mark S Walker; Arthur C Houts; Edward J Stepanski
Journal:  Breast       Date:  2009-04-01       Impact factor: 4.380

9.  Closing the loop: physician communication with diabetic patients who have low health literacy.

Authors:  Dean Schillinger; John Piette; Kevin Grumbach; Frances Wang; Clifford Wilson; Carolyn Daher; Krishelle Leong-Grotz; Cesar Castro; Andrew B Bindman
Journal:  Arch Intern Med       Date:  2003-01-13

10.  Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Authors:  C Davies; J Godwin; R Gray; M Clarke; D Cutter; S Darby; P McGale; H C Pan; C Taylor; Y C Wang; M Dowsett; J Ingle; R Peto
Journal:  Lancet       Date:  2011-07-28       Impact factor: 79.321

View more
  18 in total

1.  It's not an easy fix: Adherence to adjuvant endocrine therapy after breast cancer.

Authors:  Leah K Lambert; Lynda G Balneaves; A Fuchsia Howard
Journal:  Can Oncol Nurs J       Date:  2021-05-01

2.  Study of the uses of Information and Communication Technologies by Pain Treatment Unit Physicians.

Authors:  Jorge Muriel Fernandez; María José Sánchez Ledesma; Manuel López Millan; María Begoña García Cenador
Journal:  J Med Syst       Date:  2017-03-27       Impact factor: 4.460

3. 

Authors:  Leah K Lambert; Lynda G Balneaves; A Fuchsia Howard
Journal:  Can Oncol Nurs J       Date:  2021-05-01

4.  Patient-clinician interactions and disparities in breast cancer care: the equality in breast cancer care study.

Authors:  Felisa A Gonzales; Meera Sangaramoorthy; Laura A Dwyer; Salma Shariff-Marco; Amani M Allen; Allison W Kurian; Juan Yang; Michelle M Langer; Laura Allen; Bryce B Reeve; Stephen H Taplin; Scarlett Lin Gomez
Journal:  J Cancer Surviv       Date:  2019-10-23       Impact factor: 4.442

5.  Racial and geographic disparities in adherence and discontinuation to adjuvant endocrine therapy in Texas Medicaid-insured patients with breast cancer.

Authors:  Albert J Farias; Wen-Hsing Wu; Xianglin L Du
Journal:  Med Oncol       Date:  2018-06-20       Impact factor: 3.064

6.  Racial Differences in Adjuvant Endocrine Therapy Use and Discontinuation in Association with Mortality among Medicare Breast Cancer Patients by Receptor Status.

Authors:  Albert J Farias; Xianglin L Du
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-05-17       Impact factor: 4.254

Review 7.  Marginalized patient identities and the patient-physician relationship in the cancer care context: a systematic scoping review.

Authors:  Elizabeth Palmer Kelly; Julia McGee; Samilia Obeng-Gyasi; Chelsea Herbert; Rosevine Azap; Alizeh Abbas; Timothy M Pawlik
Journal:  Support Care Cancer       Date:  2021-07-01       Impact factor: 3.603

8.  Health Literacy, Language, and Cancer-Related Needs in the First 6 Months After a Breast Cancer Diagnosis.

Authors:  Christine M Gunn; Michael K Paasche-Orlow; Sharon Bak; Na Wang; Jennifer Pamphile; Kerrie Nelson; Samantha Morton; Tracy A Battaglia
Journal:  JCO Oncol Pract       Date:  2020-03-27

9.  Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients.

Authors:  Georg Lodde; Andrea Forschner; Jessica Hassel; Lena M Wulfken; Friedegund Meier; Peter Mohr; Katharina Kähler; Bastian Schilling; Carmen Loquai; Carola Berking; Svea Hüning; Kerstin Schatton; Christoffer Gebhardt; Julia Eckardt; Ralf Gutzmer; Lydia Reinhardt; Valerie Glutsch; Ulrike Nikfarjam; Michael Erdmann; Andreas Stang; Bernd Kowall; Alexander Roesch; Selma Ugurel; Lisa Zimmer; Dirk Schadendorf; Elisabeth Livingstone
Journal:  Cancers (Basel)       Date:  2021-05-12       Impact factor: 6.639

10.  Both "Vitamin L for Life" and "One Milligram of Satan": A Multi-Perspective Qualitative Exploration of Adjuvant Endocrine Therapy Use after Breast Cancer.

Authors:  Kirsti I Toivonen; Devesh Oberoi; Kathryn King-Shier; Katherine-Ann L Piedalue; Joshua A Rash; Linda E Carlson; Tavis S Campbell
Journal:  Curr Oncol       Date:  2021-07-05       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.